Clinical Trials Logo

Pharmacodynamics of ASP8232 clinical trials

View clinical trials related to Pharmacodynamics of ASP8232.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02218099 Completed - Healthy Subjects Clinical Trials

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease

Start date: September 16, 2013
Phase: Phase 1/Phase 2
Study type: Interventional

This study consists of two parts. Part 1 evaluates the effect of renal impairment on the PK and PD of a single dose of ASP8232. In addition, the safety and tolerability will be assessed. Part 2 evaluates the PK, PD, and safety and tolerability of multiple doses of ASP8232 compared with placebo in Type 2 Diabetes Mellitus (T2DM) subjects with Chronic Kidney Disease (CKD).